Valion Bio VBIO
NASDAQ VBIO
$2.20 -0.20 (-8.33%)
At close: Sep 10, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Intangibles (2025 - 2026)

Valion Bio (VBIO) posted Intangibles of $2.2 million for Q2 2026, little changed on a QoQ basis from $2.2 million in Q4 2025.

Analysis

Valion Bio (VBIO) Intangibles (2025 - 2026) Analysis & Trends

Valion Bio has reported Intangibles for 2 years, with the latest figure at $2.2 million in Q2 2026.

  • On a quarterly basis, Intangibles changed N/A year-over-year to $2.2 million in Q2 2026; TTM through Jun 2026 was $2.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.2 million, changed N/A from the prior year.
  • Intangibles was $2.2 million for Q2 2026 at Valion Bio, roughly flat from $2.2 million in the prior quarter.
  • The five-year high for Intangibles was $2.2 million in Q3 2025, with the low at $2.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 266.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Valion Bio 298,792.01 -1.90 Mn -45,000.00 2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Dec 31, 2025 2.24 Mn
Sep 30, 2025 2.24 Mn